Traditionally, drug research has focused on tiny agents, but peptide collaborations are rapidly demonstrating momentum. This novel approach involves combining peptidic sequences with alternative medicinal modalities to tackle challenging disease mechanisms. By leveraging the unique properties of amino acid sequences – such as substantial specific